Aarti Pharmalabs Limited (AARTIPHARM) Share Analysis
NSE · Healthcare · Pharmaceuticals
Aarti Pharmalabs Limited (NSE: AARTIPHARM) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY Microcap 250. As of 14 Nov 2026, the share price was ₹998.00, P/E 34.8, ROE 8.59%.
Get the AI verdict on AARTIPHARM: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
AARTIPHARM chart with trendlines
Is AARTIPHARM a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Aarti Pharmalabs Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
AARTIPHARM key facts
| Price and valuation | |
|---|---|
| Share price | ₹998.00 |
| Market cap | ₹9,049 Cr |
| P/E ratio | 34.8 |
| P/B ratio | 4.01 |
| EPS | ₹28.31 |
| Book value per share | ₹249.00 |
| Dividend yield | 0.35% |
| 52-week range | |
| 52-week high | ₹1,019.50 |
| 52-week low | ₹585.00 |
| Face value | ₹5.00 |
| Shareholding pattern | |
| Promoters | 39.66% |
| FIIs | 8.16% |
| DIIs | 8.4% |
| Public | 43.78% |
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.